Health Condition 1: N859- Noninflammatory disorder of uterus, unspecified
Conditions
Interventions
Intervention1: GROUP E (Continuous Epidural Analgesia): This group of patients will recieve 3.5 ml of 0.5% bupivacaine in spinal anesthesia. At the end of surgery, a bolus dose of 5 ml of 0.2% Ropivac
Sponsors
Sri Venkateshwaraa Medical College Hospital Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: All patients of ASA Status 1&2 undergoing Gynecological Abdominal surgeries
Exclusion criteria
Exclusion criteria: Patient belonging to ASA3 and beyond Coagulation disorder and Thrombocytopenia Infection at the site of injection Allergy to Local anesthetics Long-term use of NSAIDS psychiatric disorder Patient converted from spinal to general anesthesia Patient allergic to diclofenac sodium
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of postoperative analgesia Timepoint: At 0 minute half an hourly for 1 hour followed by 6th hourly until 36 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Requirement of rescue analgesia Hemodynamic changes Wound infection Post operative nausea and vomiting.Timepoint: At 0 minutes half an hourly for 1 hour followed by 6th hourly until 36 hours. | — |
Countries
India
Contacts
Public ContactRaghuraman M S
SRI VENKATESHWARAA MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE
Outcome results
None listed